Cutler Group LP Fortress Biotech, Inc. Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.8 - $1.5 $851 - $1,596	-1,064 Reduced 21.01%	4,000 $3,000
Q1 2022 Apr 14, 2022	SELL	$1.24 - $2.75 $1,160 - $2,574	-936 Reduced 15.6%	5,064 $6,000
Q4 2021 Jan 18, 2022	BUY	$2.42 - $3.65 $4,840 - $7,300	2,000 Added 50.0%	6,000 $15,000
Q3 2021 Oct 26, 2021	SELL	$2.82 - $3.7 $12,069 - $15,836	-4,280 Reduced 51.69%	4,000 $12,000
Q2 2021 Jul 19, 2021	BUY	$3.5 - $5.48 $14,980 - $23,454	4,280 Added 107.0%	8,280 $29,000
Q2 2020 Jul 22, 2020	SELL	$1.83 - $3.16 $915 - $1,580	-500 Reduced 11.11%	4,000 $10,000
Q2 2018 Aug 10, 2018	SELL	$2.92 - $5.1 $1,460 - $2,550	-500 Reduced 10.0%	4,500 $13,000
Q3 2017 Oct 17, 2017	BUY	$3.83 - $4.89 $19,150 - $24,450	5,000	5,000 $22,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $173M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.